Sort by
Refine Your Search
-
the lives of people with rare and common diseases. Built on Nobel Prize-winning science, Alnylam has delivered the breakthroughs that made RNAi therapeutics possible and are just at the beginning of
-
founded to discover, create, test and deliver transformative medicines to treat patients who suffer from genetic diseases. BridgeBio's pipeline of development programs ranges from early science to
-
data, and expand their scientific knowledge to render clinical insights and contribute to meeting the needs of healthcare professionals. About Takeda Takeda is focused on creating better health for
Enter an email to receive alerts for data-science-"https:" "https:" positions